🔎 Trials Near Me

Domov › Nemalicelični pljučni rak › Minnesota › Minneapolis

Klinične študije za Nemalicelični pljučni rak v Minneapolis, MN

27 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Minneapolis in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Vključevanje udeležencevFaza 3
  • Abbott-Northwestern Hospital, Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT07388524

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Vključevanje udeležencevFaza 3
  • Abbott-Northwestern Hospital, Minneapolis
  • Hennepin County Medical Center, Minneapolis
  • Minneapolis VA Medical Center, Minneapolis
  • in še 1
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT04267848

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Vključevanje udeležencevFaza 2
  • Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Vključevanje udeležencevFaza 3
  • Abbott-Northwestern Hospital, Minneapolis
  • Minneapolis VA Medical Center, Minneapolis
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06498635

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Vključevanje udeležencevFaza 3
  • Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07361497

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 3
  • Minnesota Oncology Hematology, P.A..., Minneapolis
  • Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07144280

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Vključevanje udeležencevFaza 3
  • Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0027), Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06312137

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Vključevanje udeležencevFaza 3
  • Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0115), Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06170788

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Vključevanje udeležencevFaza 3
  • Hennepin County Medical Center, Minneapolis
  • Metro Minnesota Community Oncology Research Consortium (MMCORC), Saint Louis Park · 5 mi stran
  • Park Nicollet Frauenshuh Cancer Center, Saint Louis Park · 5 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06758401

Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

Vključevanje udeležencevFaza 2
  • Abbott-Northwestern Hospital, Minneapolis
  • Health Partners Inc, Minneapolis
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT03191149

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Vključevanje udeležencevFaza 1/2
  • Minnesota Oncology and Hematology PA, Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT05267626

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Vključevanje udeležencevFaza 3
  • Clinical Study Site, Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT06767514

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Vključevanje udeležencevFaza 1/2
  • Masonic Cancer Center University of Minnesota, Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT05786924

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

Vključevanje udeležencevFaza 3
  • Allina Health Cancer Institute - Abbott Northwestern Hospital ( Site 0146), Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06422143

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • University of Minnesota Masonic Cancer Center, Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07216105

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Vključevanje udeležencevFaza 1
  • Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 6. jul. 2026 · NCT04389632

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Vključevanje udeležencevFaza 2
  • University of Minnesota, Minneapolis
Starost 18–70 · Vsi spoli · Posodobljeno 26. jun. 2026 · NCT04614103

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Vključevanje udeležencevFaza 1
  • M Health Fairview University of Minnesota Medical Center - East Bank /ID# 276200, Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT05005403

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2
  • Abbott-Northwestern Hospital, Minneapolis
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2/3
  • Abbott-Northwestern Hospital, Minneapolis
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06616584

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

Vključevanje udeležencevFaza 2
  • University of Minnesota, Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT04317534

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Vključevanje udeležencevOpazovalna študija
  • Abbott-Northwestern Hospital, Minneapolis
  • Hennepin County Medical Center, Minneapolis
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 17. mar. 2026 · NCT06418204

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Vključevanje udeležencev
  • Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Starost 18 in več · Vsi spoli · Posodobljeno 19. feb. 2026 · NCT02984761

Študije za Nemalicelični pljučni rak v drugih mestih

Druge študije v Minneapolis

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.